Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 252,004 | 142,117 | 9,238 | 17,983 | 28,319 |
| Marketable Securities | 40,865 | 38,531 | N/A | N/A | N/A |
| Receivables | 142 | 999 | 1,165 | 1,731 | 1,113 |
| Inventories | N/A | N/A | N/A | 1,013 | 1,094 |
| Other current assets | 0 | 5,266 | 5,301 | 0 | 0 |
| TOTAL | $294,237 | $188,200 | $16,837 | $21,688 | $31,954 |
| Non-Current Assets | |||||
| PPE Net | 14,747 | 14,302 | 5,576 | 7,012 | 7,043 |
| Intangibles | 74,062 | 74,062 | 74,062 | 77,319 | 77,319 |
| Other Non-Current Assets | 2,873 | 1,722 | 1,416 | 4,499 | 3,829 |
| TOTAL | $91,682 | $90,086 | $81,054 | $88,830 | $88,191 |
| Total Assets | $385,919 | $278,286 | $97,891 | $110,518 | $120,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,127 | 6,027 | 6,909 | 3,867 | 4,906 |
| Accrued Expenses | 2,309 | 1,828 | 3,588 | 3,907 | 3,350 |
| Other current liabilities | N/A | 5,070 | 5,072 | N/A | N/A |
| TOTAL | $10,610 | $14,503 | $15,664 | $8,115 | $8,589 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,651 | 1,663 | 1,676 | 1,689 | 1,701 |
| Deferred Revenues | 1,400 | 1,400 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,469 | 1,037 | 780 | 1,944 | 1,202 |
| TOTAL | $34,312 | $33,892 | $7,048 | $3,633 | $2,903 |
| Total Liabilities | $44,922 | $48,395 | $22,712 | $11,748 | $11,492 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,428 | 62,263 | 58,692 | 28,057 | 28,057 |
| Common Shares | 67 | 587 | 28 | 281 | 280 |
| Retained earnings | -176,428 | -164,724 | -152,440 | -127,765 | -117,409 |
| TOTAL | $340,997 | $229,891 | $75,179 | $98,770 | $108,653 |
| Total Liabilities And Equity | $385,919 | $278,286 | $97,891 | $110,518 | $120,145 |